Hilton San Francisco Union Square

Park Hotels & Resorts Inc. Announces Lawsuit Related to $725 Million Non-Recourse CMBS Loan Secured By Two of its San Francisco Hotels

Retrieved on: 
Thursday, October 26, 2023
Sale, PK, CMBS, NYSE, Flamingo Resort, Inc. v. United States, Parc 55 San Francisco, Loan, Hilton San Francisco Union Square, Hilton

TYSONS, Va., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Park Hotels & Resorts Inc. (NYSE: PK) (“Park” or the “Company”) announced today that the trustee under the $725 million non-recourse CMBS loan (“Loan”), by and through its special servicer, filed a lawsuit against the borrower entities related to the cessation of payments on the Loan.

Key Points: 
  • TYSONS, Va., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Park Hotels & Resorts Inc. (NYSE: PK) (“Park” or the “Company”) announced today that the trustee under the $725 million non-recourse CMBS loan (“Loan”), by and through its special servicer, filed a lawsuit against the borrower entities related to the cessation of payments on the Loan.
  • In connection with the lawsuit, the trustee requested the appointment of a receiver to take control of the hotels securing the Loan – the 1,921-room Hilton San Francisco Union Square and the 1,024-room Parc 55 San Francisco.
  • Once appointed by the court, the receiver will have complete and exclusive control and possession of the hotels and will maintain Hilton and its workforce to manage the ongoing operations at the hotels.
  • The receivership will place control of the hotels as well as the benefits and burdens of their operations with the trustee and the court-appointed receiver.

Date and Time Announced for First Wave BioPharma CEO James Sapirstein’s Presentation at the 2023 BIO Investor Forum

Retrieved on: 
Tuesday, October 10, 2023
BIO, First wave, PDT, BOCA, Franciscans, Hilton San Francisco Union Square, Pharmaceutical industry

BOCA RATON, Fla., Oct. 10, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that Chairman, President, and CEO of First Wave BioPharma James Sapirstein’s presentation at the 2023 BIO Investor Forum will take place at 11:15 a.m. PDT on October 17, 2023 in the Franciscan B Room at the Hilton San Francisco.

Key Points: 
  • BOCA RATON, Fla., Oct. 10, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that Chairman, President, and CEO of First Wave BioPharma James Sapirstein’s presentation at the 2023 BIO Investor Forum will take place at 11:15 a.m. PDT on October 17, 2023 in the Franciscan B Room at the Hilton San Francisco.
  • In addition to the presentation, members of the First Wave BioPharma management team will conduct one-on-one meetings with registered investors at the conference, showcasing the company’s business and clinical development strategy, recent corporate achievements, and anticipated milestones.
  • Details of the presentation are as follows:

Vivani Medical to Present at BIO Investor Forum

Retrieved on: 
Monday, October 16, 2023
Medical Supplies, Health, Medical Devices, Diabetes, Health Technology, Pharmaceutical, Biotechnology, BIO, PDT, Medicine, Vivani, Obesity, Hilton San Francisco Union Square, Mobile phone, Management, Pharmaceutical industry

Vivani Medical, Inc. (NASDAQ: VANI ) (the “Company” or “Vivani”), an innovative, preclinical-stage biopharmaceutical company that develops novel, long-term drug implants, announced today that it will present at the BIO Investor Forum at 2:00 p.m. PDT at the Hilton San Francisco Union Square on October 18, 2023.

Key Points: 
  • Vivani Medical, Inc. (NASDAQ: VANI ) (the “Company” or “Vivani”), an innovative, preclinical-stage biopharmaceutical company that develops novel, long-term drug implants, announced today that it will present at the BIO Investor Forum at 2:00 p.m. PDT at the Hilton San Francisco Union Square on October 18, 2023.
  • Vivani President and Chief Executive Officer Adam Mendelsohn, Ph.D., will provide updates on the company, its proprietary NanoPortal™ implant technology and the Company’s lead program, NPM-119, a miniaturized, six-month, GLP-1 implant currently under development for the treatment of type 2 diabetes and obesity.

DIMERx to Present at BIO Investor Forum 2023

Retrieved on: 
Wednesday, October 4, 2023
Health, General Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, BIO, Entrepreneurship, Hilton San Francisco Union Square, Rare-earth element, Nightclub, Employment agency

DIMERx, Inc. , an advance-stage biopharmaceutical company, today announced that Nikhilesh N. Singh, Ph.D., Co-Founder and Chief Executive Officer, will present at the BIO Investor Forum 2023 , being held October 17-18, 2023, in San Francisco.

Key Points: 
  • DIMERx, Inc. , an advance-stage biopharmaceutical company, today announced that Nikhilesh N. Singh, Ph.D., Co-Founder and Chief Executive Officer, will present at the BIO Investor Forum 2023 , being held October 17-18, 2023, in San Francisco.
  • Location: Franciscan Room D at Hilton San Francisco Union Square, 333 O’Farrell Street, San Francisco

Latest Blood Cancer Treatment Updates Presented at Annual NCCN Event During Blood Cancer Awareness Month

Retrieved on: 
Monday, September 18, 2023
Human, Acute lymphoblastic leukemia, Senior, ALL, Mantle cell lymphoma, Myelodysplastic syndrome, Malignancy, Bone marrow, Research, Hodgkin lymphoma, Doctor of Philosophy, National Comprehensive Cancer Network, NCCN, Hilton San Francisco Union Square, MDS, Congress, CAR, AML, Patient, SAN, Hematology, MM, Memorial Sloan Kettering Cancer Center, MCL, Acute leukemia, Conference, Acute myeloid leukemia, Chronic myelogenous leukemia, Multiple myeloma, Vaccine, Primary myelofibrosis, MD

SAN FRANCISCO, Sept. 18, 2023 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) 2023 Annual Congress: Hematologic Malignancies™ returns to San Francisco this week, for the first time since 2019. The meeting features insights from world-renowned experts on providing optimal, evidence-based treatment for various blood cancers, plus best practices for protecting vulnerable populations in a changing healthcare landscape.

Key Points: 
  • The live event is taking place September 22-23, 2023, at the Hilton San Francisco Union Square.
  • "We designed a comprehensive program for the entire hematology and oncology team—taking into account the latest advances, conversations, and controversies in blood cancer treatment today," said congress Chair Andrew D. Zelenetz, MD, PhD, Memorial Sloan Kettering Cancer Center.
  • "This will help us all to achieve the best possible outcomes for people with blood cancer in a rapidly evolving landscape."
  • Save the dates: the NCCN 2024 Annual Conference will be happening in Orlando, FL April 5 - 7, 2024.

First Wave BioPharma To Present at the BIO Investor Forum

Retrieved on: 
Friday, September 15, 2023
Hilton San Francisco Union Square, BIO, BOCA, First wave, Mobile phone, Sales, Pharmaceutical industry

BOCA RATON, Fla., Sept. 15, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that James Sapirstein, President and CEO, will make a company presentation at the BIO Investor Forum being held October 17-18, 2023, at the Hilton San Francisco Union Square in San Francisco.

Key Points: 
  • BOCA RATON, Fla., Sept. 15, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that James Sapirstein, President and CEO, will make a company presentation at the BIO Investor Forum being held October 17-18, 2023, at the Hilton San Francisco Union Square in San Francisco.
  • During the conference, members of the First Wave BioPharma management team will conduct one-on-one meetings with registered investors and pharmaceutical companies, showcasing the company’s business and clinical development strategy, recent corporate achievements, and anticipated milestones.

Park Hotels & Resorts Inc. Announces Cessation of Payment on $725 Million Non-Recourse CMBS Loan Secured By Two of Its San Francisco Hotels

Retrieved on: 
Monday, June 5, 2023
Hilton San Francisco Union Square, PK, RevPAR, Parc 55 San Francisco, Comparable, Flamingo Resort, Inc. v. United States, CMBS, City, ROI, NYSE, Bank

“This past week we made the very difficult, but necessary decision to stop debt service payments on our San Francisco CMBS loan,” commented Thomas J. Baltimore, Jr., Chairman and Chief Executive Officer of Park.

Key Points: 
  • “This past week we made the very difficult, but necessary decision to stop debt service payments on our San Francisco CMBS loan,” commented Thomas J. Baltimore, Jr., Chairman and Chief Executive Officer of Park.
  • “After much thought and consideration, we believe it is in the best interest for Park’s stockholders to materially reduce our current exposure to the San Francisco market.
  • That guidance does not take into account financial impacts, if any, from the cessation of payment toward the San Francisco CMBS Loan as any such impacts are uncertain at this time.
  • The Company expects to update full-year 2023 guidance as necessary once those impacts and the path forward are certain.

Luxury San Francisco Hotel Simplifies Budgeting with Updated Accounting and Forecasting Solutions

Retrieved on: 
Tuesday, May 16, 2023
Luxury, Hotel Nikko San Francisco, Bank statement, Statistics, Forecasting, OCR, Nikko Hotels, Bank reconciliation, Hilton San Francisco Union Square, Investment, Restaurant, Anzu, Data, Bank, Financial management, General ledger, Risk management, Online shopping, Hotel, Aptech, Finance

PITTSBURGH, May 16, 2023 /PRNewswire-PRWeb/ -- Business at the Hotel Nikko San Francisco is booming, especially since the property secured a spot on Forbes' 2022 list of the 13 best hotels in San Francisco. With travelers' eyes fixed on the luxury boutique hotel in Union Square, the hotel's management team began looking for new financial management tools capable of delivering macro and micro analysis of numerous data sets and assisting with planning for future investments into the property. PVNG enterprise accounting and Targetvue budgeting and forecasting solutions from Aptech fit the bill for their ability to affordably give operators the insight, flexibility and control they desired.

Key Points: 
  • After switching its legacy accounting and budgeting software to PVNG and Targetvue by Aptech, the Hotel Nikko San Francisco is prioritizing operations above all else
    PITTSBURGH, May 16, 2023 /PRNewswire-PRWeb/ -- Business at the Hotel Nikko San Francisco is booming, especially since the property secured a spot on Forbes' 2022 list of the 13 best hotels in San Francisco .
  • PVNG enterprise accounting and Targetvue budgeting and forecasting solutions from Aptech fit the bill for their ability to affordably give operators the insight, flexibility and control they desired.
  • This, combined with the wide range of offerings the hotel provides, makes accounting, budgeting, and forecasting all the more complex.
  • The 531-room Hotel Nikko San Francisco is known for its high-end Japanese-inspired decor, a wide array of amenities, and attention to detail.

NeighborWorks Training Institute in San Francisco will attract 1,400+ housing and community-development professionals

Retrieved on: 
Monday, May 1, 2023
Hilton San Francisco Union Square, Pasta â Paolina, Learning, Housing, Culture, Senior counsel, Generation, Policy, Industrial training institute, History, Black, Organization, Chinatown, San Francisco, Map, Knowledge, Entrepreneurship, Liberation, Piedmont, Mobile phone, Management, NeighborWorks America

San Francisco, CA, May 01, 2023 (GLOBE NEWSWIRE) -- More than 1,400 housing and community-development professionals from around the country will convene in San Francisco for the NeighborWorks Training Institute May 1-5 .

Key Points: 
  • San Francisco, CA, May 01, 2023 (GLOBE NEWSWIRE) -- More than 1,400 housing and community-development professionals from around the country will convene in San Francisco for the NeighborWorks Training Institute May 1-5 .
  • “San Francisco’s unique culture and innovative programs in affordable housing and community development make the city an ideal setting for the NeighborWorks Training Institute,” said NeighborWorks America President & CEO Marietta Rodriguez.
  • In addition to the training institute, NeighborWorks America supports organizations working to serve the San Francisco community throughout the year.
  • Press credentials will be available on-site at Hilton San Francisco Union Square (333 O'Farrell St, San Francisco, CA 94102.)

Blue Water Vaccines to Present at Biotech Showcase 2023 During the 41st Annual J.P. Morgan Healthcare Conference Week in San Francisco

Retrieved on: 
Monday, January 9, 2023
Union, Vaccine, Hilton San Francisco Union Square, Interest, BWV, Nightclub

Hilton San Francisco Union Square, Yosemite A (Ballroom Level)

Key Points: 
  • Hilton San Francisco Union Square, Yosemite A (Ballroom Level)
    “We are honored to present our story and progress at this year’s Biotech Showcase in San Francisco,” said Joseph Hernandez, Chairman and Chief Executive Officer of Blue Water Vaccines.
  • “We have made exciting progress in advancing and expanding our vaccine pipeline in recent months, and we look forward to sharing details at such a prestigious event with all in attendance.”
    BWV’s management will be available during the conference for one-on-one meetings.
  • Interested parties may request a one-on-one meeting at [email protected] or contact BWV at (513) 620-4101.